These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 2115769)

  • 1. Urokinase- and tissue-type plasminogen activators are suppressed by cortisol in the involuting prostate of castrated rats.
    Freeman SN; Rennie PS; Chao J; Lund LR; Andreasen PA
    Biochem J; 1990 Jul; 269(1):189-93. PubMed ID: 2115769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
    Wilson MJ; Ludowese C; Sinha AA; Estensen RD
    Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase-type plasminogen activator is increased in the involuting ventral prostate of castrated rats.
    Andreasen PA; Kristensen P; Lund LR; Danø K
    Endocrinology; 1990 May; 126(5):2567-76. PubMed ID: 2109689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between inhibition of plasminogen-activator activity and prostatic involution.
    Rennie PS; Bowden JF; Bruchovsky N; Cheng H
    Biochem J; 1988 Jun; 252(3):759-64. PubMed ID: 2458715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortisol alters gene expression during involution of the rat ventral prostate.
    Rennie PS; Bowden JF; Freeman SN; Bruchovsky N; Cheng H; Lubahn DB; Wilson EM; French FS; Main L
    Mol Endocrinol; 1989 Apr; 3(4):703-8. PubMed ID: 2498651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of urokinase plasminogen activator and matrix metalloproteinases and up-regulation of their inhibitors by a novel nutrient mixture in human prostate cancer cell lines PC-3 and DU-145.
    Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
    Oncol Rep; 2011 Dec; 26(6):1407-13. PubMed ID: 21874261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
    Sitter T; Toet K; Quax P; Kooistra T
    Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: correlation with metastatic behavior in vivo.
    Quax PH; de Bart AC; Schalken JA; Verheijen JH
    Prostate; 1997 Aug; 32(3):196-204. PubMed ID: 9254899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
    Quax PH; van Muijen GN; Weening-Verhoeff EJ; Lund LR; Danø K; Ruiter DJ; Verheijen JH
    J Cell Biol; 1991 Oct; 115(1):191-9. PubMed ID: 1918136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased activity of plasminogen activators during involution of the rat ventral prostate.
    Rennie PS; Bouffard R; Bruchovsky N; Cheng H
    Biochem J; 1984 Jul; 221(1):171-8. PubMed ID: 6431969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-dependent and calcium-independent gelatinolytic proteinase activities of the rat ventral prostate and its secretion: characterization and effect of castration and testosterone treatment.
    Wilson MJ; Strasser M; Vogel MM; Sinha AA
    Biol Reprod; 1991 May; 44(5):776-85. PubMed ID: 1868137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice.
    Ahn MY; Zhang ZG; Tsang W; Chopp M
    Brain Res; 1999 Aug; 837(1-2):169-76. PubMed ID: 10433999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases.
    Koutsilieris M; Frenette G; Lazure C; Lehoux JG; Govindan MV; Polychronakos C
    Anticancer Res; 1993; 13(2):481-6. PubMed ID: 7685989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro expression of the plasminogen activators and urokinase type plasminogen activator receptor (u-PAR) in the pig oviduct.
    Roldán-Olarte M; García DC; Jiménez-Díaz M; Valdecantos PA; Miceli DC
    Anim Reprod Sci; 2012 Dec; 136(1-2):90-9. PubMed ID: 23103014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2.
    Thorsen S; Philips M; Selmer J; Lecander I; Astedt B
    Eur J Biochem; 1988 Jul; 175(1):33-9. PubMed ID: 3136015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
    Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
    J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrilysin expression in the involuting rat ventral prostate.
    Powell WC; Domann FE; Mitchen JM; Matrisian LM; Nagle RB; Bowden GT
    Prostate; 1996 Sep; 29(3):159-68. PubMed ID: 8827084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo.
    Quax PH; van den Hoogen CM; Verheijen JH; Padro T; Zeheb R; Gelehrter TD; van Berkel TJ; Kuiper J; Emeis JJ
    J Biol Chem; 1990 Sep; 265(26):15560-3. PubMed ID: 2118527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiles of fibrinolytic components in nasal mucosa.
    Sejima T; Madoiwa S; Mimuro J; Sugo T; Ishida T; Ichimura K; Sakata Y
    Histochem Cell Biol; 2004 Jul; 122(1):61-73. PubMed ID: 15197554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.